Advocate Lutheran General Childrens Hospital — Park Ridge, Illinois

Advocate Lutheran General Childrens Hospital is a clinical research site located in Park Ridge, Illinois, United States 60068.

Crixeo Clinical Trials Trust Score: 90/100 (GOOD). This profile has not yet been claimed by the site owner.

Advocate Lutheran General Childrens Hospital has participated in 3 clinical trials with 3 currently active.

Therapeutic areas: Cardiovascular Disease and Lipoprotein(a), Atherosclerotic Cardiovascular Disease (ASCVD).

Sponsors: Novartis Pharmaceuticals.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Park Ridge

Browse all research sites in Illinois · View every site in Park Ridge

Sponsor Feasibility Report

Trust Score: 90/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Advocate Lutheran General Childrens Hospital?

Advocate Lutheran General Childrens Hospital has a Crixeo Trust Score of 90/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Advocate Lutheran General Childrens Hospital conducted?

Advocate Lutheran General Childrens Hospital has 3 clinical trials on record, with 3 currently active. Their work covers Cardiovascular Disease and Lipoprotein(a), Atherosclerotic Cardiovascular Disease (ASCVD).

Is Advocate Lutheran General Childrens Hospital accredited by Crixeo Clinical Trials?

Advocate Lutheran General Childrens Hospital has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Advocate Lutheran General Childrens Hospital?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.